An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma. (Q39703281)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

toll-like receptor

0 references

evasion of host immune response

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

12

object named as

Stefan Endres

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Collin Jacobs

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Klaus Heckelsmiller

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jiwu Wei

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Franz Bauernfeind

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jonathan Ellermeier

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Ulrich Kisser

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Christian A Bauer

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Marc Dauer

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Andreas Eigler

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Eugene Maraskovsky

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Max Schnurr

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

0 references

publication date

1 February 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

128

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

897-907

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20473889%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Immunosuppressive strategies that are mediated by tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Regulatory T cells in the past and for the future

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Development of TLR9 agonists for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Survivin expression and its clinical significance in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25399

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39703281&oldid=2089016052"